Overview

Nasal Decolonization of Dialysis Patients Noses

Status:
Enrolling by invitation
Trial end date:
2024-03-31
Target enrollment:
Participant gender:
Summary
Hemodialysis patients are at high-risk for infections, specifically Staphylococcus aureus infections. The investigators propose to 1) implement a novel intervention (nasal povidone-iodine at each hemodialysis session) to prevent S. aureus infections using a stepped-wedge cluster randomized trial, and 2) evaluate the feasibility and acceptability of this intervention. If successful, this intervention can be used among hemodialysis patients, and evaluated in other high-risk patient populations to prevent S. aureus infections.
Phase:
Phase 4
Details
Lead Sponsor:
Marin L. Schweizer, PhD
Collaborators:
3M
Agency for Healthcare Research and Quality (AHRQ)
Emory Healthcare
University of Illinois at Chicago
University of Pennsylvania
Washington University School of Medicine
Treatments:
Cadexomer iodine
Iodine
Povidone
Povidone-Iodine